JBS Q1 2026 First Take

JBS reported a soft Q1 2026 with a -5% EBITDA miss relative to consensus and widespread margin contraction, though top-line growth and cash flow exceeded expectations. Goldman Sachs remains Buy-rated, attributing the weakness to temporary factors and citing buoyant global demand.

Key Takeaways

• 1.JBS delivered a soft Q1'26 with adjusted EBITDA missing consensus by -5% and margin contraction across most business units.
• 2.Global demand remained strong, leading to a 10% beat on the consolidated top line and record Q1 sales in several segments.
• 3.Free cash flow generation was better than expected due to moderate inventory buildup and acquisition gains, despite the EBITDA miss.

Table of Contents

• JBS (JBS): Q1'26 First Take: A (temporary) step back
• Disclosure Appendix
• GS Factor Profile
• M&A Rank
• Quantum
• Disclosures
• Price target and rating history chart(s)
• Regulatory disclosures
• Ratings, coverage universe and related definitions
• Global product; distributing entities
• General disclosures

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial